Neuroinflammation in Parkinson's disease [PD] is a process that occurs alongside the loss of
dopaminergic neurons, and is associated with alterations to many cell types, most notably …

Most acute and chronic neurodegenerative conditions are accompanied by
neuroinflammation; yet the exact nature of the inflammatory processes and whether they …

Parkinson's disease (PD) is a common neurodegenerative disorder primarily characterized
by the death of dopaminergic neurons that project from the substantia nigra pars compacta …

Parkinson's disease (PD) is the second most common neurodegenerative disease, after
Alzheimer's disease. The potential causes of PD remain uncertain, but recent studies …

During the last two decades, a wealth of animal and human studies has implicated
inflammation-derived oxidative stress and cytokine-dependent neurotoxicity in the …

Parkinson's disease (PD) is the first and second most prevalent motor and
neurodegenerative disease, respectively. The clinical symptoms of PD result from a loss of …

Overview 3. Clinical and epidemiological evidence for inflammation in Parkinson's Disease
3.1. Cell types involved in neuroinflammation 3.2. Inflammatory mediators in …

Parkinson's Disease (PD) is a common neurodegenerative disease characterized by the
progressive degeneration of nigrostriatal dopaminergic (DA) neurons. Although the …

Neuroinflammation plays a key role in the pathogenesis of Parkinson's disease (PD).
Epidemiologic, animal, human, and therapeutic studies support the role of oxidative stress …

Parkinson's disease (PD) is a neurodegenerative movement disorder characterized by the
progressive loss of dopaminergic neurons in the substantia nigra and depletion of dopamine …